Davis Polk hosts a series of webinars focused on legal considerations for life sciences and healthcare companies. In this installment, senior lawyers discuss considerations and strategies for navigating the use of artificial intelligence in drug development. We discuss:

  • Recent trends in the use of AI in the life sciences sector
  • Key legal risks in using AI
  • Strategies for mitigating or managing risks related to the use of AI

This program is designed for in-house counsel, corporate development executives, and strategic decision-makers. 


Related materials

CLE form

Webinar slides

Copy link to share post